Navigation Links
Genzyme Withdraws Bioenvision's European Filing of Evoltra(R) in Elderly AML Patients
Date:3/19/2008

Will Resubmit With New Data from Ongoing Studies

CAMBRIDGE, Mass., March 19 /PRNewswire-FirstCall/ -- Genzyme Corp. (Nasdaq: GENZ) today announced the withdrawal of the European application to extend the Evoltra(R) (clofarabine) product label to include the treatment of elderly patients with acute myeloid leukemia (AML). This application and the data on which it was based were filed by Bioenvision, Ltd. before the company was acquired by Genzyme last year.

In a letter to the European Medicines Agency (EMEA) on behalf of Bioenvision, Genzyme states that the withdrawal is based on the EMEA's Committee for Medicinal Products for Human Use (CHMP) assessment that the data from the BIOV121 study are not sufficient to support a recommendation for market approval at this time. Bioenvision is now a wholly-owned subsidiary of Genzyme.

"As we expected, the filing that Bioenvision submitted to the EMEA was not sufficient to support approval in adult AML and our subsequent conversations with the CHMP have confirmed this assessment," stated Mark J. Enyedy, president of Genzyme Oncology, a business unit of Genzyme Corp. "We have engaged in a positive dialogue with the Rapporteurs regarding the requirements for approval and will develop a new submission to include data from one or more ongoing clinical studies of clofarabine in this patient population for submission possibly as early as the fourth quarter of this year."

In the United States, Genzyme has completed enrollment for a pivotal study in previously untreated, older adult patients with AML who are unlikely to benefit from standard intensive induction chemotherapy. Data from this study, known as CLASSIC II, are expected to provide substantial evidence for expa
'/>"/>

SOURCE Genzyme Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Novel Angiogenic Drugs, Including a Future Blockbuster from Genzyme, Could Revolutionize Treatment of Peripheral Arterial Disease
2. Genzyme Begins Major Expansion of Boston Manufacturing Facility
3. Genzyme Affirms Purchase Price for Bioenvision at $5.60 Per Outstanding Share
4. Genzyme Receives Approval to Market Elaprase(R) in Japan
5. Genzyme Recognized by Scientists as a Top Employer
6. Genzyme to Participate in FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease
7. FDA Approves Genzymes Renvela(TM) for Dialysis Patients
8. Genzyme Launches Cholestagel(R) in Europe
9. BioVex Appoints Genzyme Executive, Jan van Heek, as Chairman of the Board of Directors
10. Genzyme and Sunway to Collaborate on Gene Therapy Program in China
11. Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... July 30, 2015 , ... GEA's Pony™ NS2006L ... operation up to 1500 bar. The sanitary design gauge of the NS2006L is ... , The Pony™ NS2006L homogenizer is an ideal solution for the processing of ...
(Date:7/29/2015)... -- According to a new market research report, ... (2015-2020), , published by Mordor Intelligence, the Global market is ... of 2020, with North America being ... the global market size. The Global market for Stem Cells ... the period of (2015-2020).      (Logo: http://photos.prnewswire.com/prnh/20150428/740799) , ...
(Date:7/29/2015)... MONTREAL , July 29, 2015 /PRNewswire/ - BioAmber Inc. ... Laurin , the Company,s Chief Financial Officer has resigned.  ... former Chief Financial Officer who retired in December 2014, ... search for a permanent successor.     Andy ... Mr. Laurin and ensure a smooth transition.  Andy was ...
(Date:7/29/2015)... ... July 29, 2015 , ... G-CON Manufacturing, Inc., the leading ... 2nd generation cell therapy POD® design. The 2nd generation portfolio not only delivers ... new POD® design. , “G-CON first offered our miniPOD CT product line ...
Breaking Biology Technology:GEA Announces the Pony™ NS2006L… a Self-contained, High Pressure Lab Homogenizer for Product Development Ensuring Maximum Efficiency and Safety 2Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players 2Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players 3BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 2G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 3
... William Heiser, Ph.D., Research and Development Department,Genetic Systems Division, ... Summary ... have found that the most important factors which must be,optimized ... other parameters, within a,broad range, usually has minimal effect on ...
... Volker Wippersteg, Katja Kapp, Werner Kunz, and Christoph G ... , ... Schistosomes are parasitic helminths that cause bilharzia (schistosomiasis) , ... of worldwide significance (Savioli et al.1997). , ...
... The following protocol is an adaptation for protein determination,in the presence of ... 50 mM BME or 5 mM DTT., ... DC Protein Assay, Bio-Rad Laboratories catalog numbers 500-0116, ... Iodoacetamide, DTT, 1 g, Bio-Rad ...
Cached Biology Technology:Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 2Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 3Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 4Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 5Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 6Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 7Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 8Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 9Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 10Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 11Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 12Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 13Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 14Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 15Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 16Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 17Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 2Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 3Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 4Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 5Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 6Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 7Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 8Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 9Modification of Bio-Rad DC Protein Assay for Use With Thiols 2
(Date:7/31/2015)... julio de 2015 BGI llevará a cabo la ... 22 al 25 de octubre de 2015, en ... celebra su décimo aniversario este año. Desde su inauguración ... las reuniones anuales más influyentes del mundo en los ... conferencias científicas más dinámicas, entusiastas y amenas. ...
(Date:7/31/2015)... juillet 2015 La 10e Conférence internationale ... organisée par le BGI du 22 au 25 ... en Chine. La conférence célèbre son ... 2006, l,ICG est devenue l,une des réunions annuelles ... « omiques » et c,est aussi la plus dynamique, la ...
(Date:7/31/2015)... 31. Juli 2015 Die 10. internationale Konferenz zu ... veranstaltet und findet vom 22. bis 25. Oktober ... statt. Die Konferenz feiert in ... 2006 ist die ICG weltweit zu einem der ... ist eines der dynamischsten, enthusiastischsten und angenehmsten wissenschaftlichen ...
Breaking Biology News(10 mins):La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 2Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 3
... CLEVELAND University Hospitals (UH) Case Medical Center ... a catheter-based treatment for heart failure, today announced ... Partitioning Device, a Percutaneous Ventricular Restoration Therapy (PVRT) ... The two-year clinical results were presented ...
... NJ May 17th 2012. Wiley-Blackwell, the scientific, technical, medical ... today announced the launch of Food Science & Nutrition ... The journal will provide authors with a new platform for ... published in collaboration with the Society of Chemical Industry, the ...
... the largest reservoir in the United States, but users are ... average year, which threatens the water supply for agriculture and ... and Trade system of interstate water trading. The proposal, published ... (JAWRA), builds on the success of such an initiative in ...
Cached Biology News:UH Case Medical Center, CardioKinetix reveal promising data for treatment for heart failure 2UH Case Medical Center, CardioKinetix reveal promising data for treatment for heart failure 3Wiley-Blackwell launches new open-access journal: Food Science & Nutrition 2Could cap and trade for water solve problems facing the United States' largest rivers? 2
6 x Blend of rTth DNA Polymerase and Tli to provide optimized amounts of both 5-3 and 3-5 proofreading activity...
... are used to assess the effect of drugs ... mice and rats using one unit in a ... animals are placed on textured drums to avoid ... sensing platforms below, its test results are recorded. ...
... Virus Reverse Transcriptase (M-MLV RT) is an RNA-dependent ... synthesis with long messenger RNA templates (>5kb). The ... of M-MLV and consists of a single subunit ... H activity of M-MLV RT is weaker than ...
... determination of digitonin and digoxin. Physical form: Lyophilized ... and 0.06% NaCl Preparation Note: Sodium iodide ... Res. Commun., 19, 755 (1965). Unit Definition: ... phosphorus from ATP per min at pH 7.4 ...
Biology Products: